Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
AMAG Pharmaceuticals, Inc. is a developer and manufacturer of therapeutics for maternal and women's health. The Zacks Consensus Estimate for its current year earnings has been revised 26% downward over the last 30 days.
Annaly Capital Management, Inc. (NLY - Free Report) invests in as well as finances residential and commercial assets. The Zacks Consensus Estimate for its current year earnings has been revised 9.4% downward over the last 30 days.
ArcelorMittal (MT - Free Report) is the owner and operator of steel manufacturing and mining facilities. The Zacks Consensus Estimate for its current year earnings has been revised 16.4% downward over the last 30 days.
Diplomat Pharmacy, Inc. is the owner and operator of an independent specialty pharmacy. The Zacks Consensus Estimate for its current year earnings has been revised 81% downward over the last 30 days.
Energizer Holdings, Inc. (ENR - Free Report) is a manufacturer of household batteries, specialty batteries and lighting products. The Zacks Consensus Estimate for its current year earnings has been revised 2% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
AMAG Pharmaceuticals, Inc. is a developer and manufacturer of therapeutics for maternal and women's health. The Zacks Consensus Estimate for its current year earnings has been revised 26% downward over the last 30 days.
Annaly Capital Management, Inc. (NLY - Free Report) invests in as well as finances residential and commercial assets. The Zacks Consensus Estimate for its current year earnings has been revised 9.4% downward over the last 30 days.
ArcelorMittal (MT - Free Report) is the owner and operator of steel manufacturing and mining facilities. The Zacks Consensus Estimate for its current year earnings has been revised 16.4% downward over the last 30 days.
Diplomat Pharmacy, Inc. is the owner and operator of an independent specialty pharmacy. The Zacks Consensus Estimate for its current year earnings has been revised 81% downward over the last 30 days.
Energizer Holdings, Inc. (ENR - Free Report) is a manufacturer of household batteries, specialty batteries and lighting products. The Zacks Consensus Estimate for its current year earnings has been revised 2% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MT - FREE
Get the latest research report on ENR - FREE
Get the latest research report on NLY - FREE